GRP
AKBA icon

Global Retirement Partners’s Akebia Therapeutics AKBA Stock Holding History

Global Retirement Partners’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,984
Closed -$27K – 1618
2020
Q2 		$27K Buy
1,984
+330
+20% +$3.41K ﹤0.01% 800
2020
Q1 		$13K Buy
1,654
+69
+4% +$537 ﹤0.01% 931
2019
Q4 		$10K Buy
1,585
+170
+12% +$808 ﹤0.01% 1143
2019
Q3 		$6K Hold
1,415
– – ﹤0.01% 1231
2019
Q2 		$7K Hold
1,415
– – ﹤0.01% 1189
2019
Q1 		$12K Buy
1,415
+398
+39% +$2.73K ﹤0.01% 995
2018
Q4 		$6K Buy
1,017
+848
+502% +$6.64K ﹤0.01% 1085
2018
Q3 		$1K Hold
169
– – ﹤0.01% 1453
2018
Q2 		$2K Buy
+169
New +$1.69K ﹤0.01% 1362

Other funds holding AKBA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Global Retirement Partners's AKBA Position: Q3 2020 in Review

Global Retirement Partners sold out of Akebia Therapeutics (AKBA) in Q3 2020, closing a stake of 1,984 shares — an estimated $27K sold.

Global Retirement Partners first reported a position in AKBA in Q2 2018 and held it in 9 quarters. The position peaked at $27K in Q2 2020. 164 funds tracked by Wall St. Rank hold AKBA as of Q3 2020.

  • Global Retirement Partners reported no remaining Akebia Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Global Retirement Partners sold 1,984 Akebia Therapeutics shares in Q3 2020, an estimated $27K.
  • Global Retirement Partners first reported a position in Akebia Therapeutics in Q2 2018 and held it in 9 quarters.
  • Global Retirement Partners's Akebia Therapeutics position peaked at $27K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2020.

Based on Global Retirement Partners's 13F filing for Q3 2020, filed 9 Oct 2020.